Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Research and Development
King's College London, bit.bio collaboration launched to build multicell brain models
A collaboration has been launched in the U.K. to build multicell models of the human brain deemed vital to develop novel therapies for neuronal and psychiatric disorders.
December 5, 2023
UK Biobank shares 500K WGS linked to 15 years of health data
UK Biobank has made deidentified whole genome sequencing (WGS) data on 500,000 people available, enabling researchers around the world to analyze the genomics results alongside 15 years of health data on the individuals.
December 4, 2023
AI-powered blood test supports risk stratification of heart disease patients
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
Siemens Healthineers contracts with NIAID to develop NGS-based sepsis test
Siemens Healthineers has secured a three-year, $5.5 million contract with the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health, to develop a test to improve sepsis treatment.
November 22, 2023
Bit.bio unveils cell therapy candidate for liver conditions
Synthetic biology company bit.bio has unveiled a lead cell therapy candidate as a treatment for life-threatening liver conditions, and it has set out its broader cell therapy pipeline.
November 22, 2023
Nanopore Technologies, Day Zero Diagnostics to collaborate on sepsis diagnostic solution
Oxford, U.K.-based Oxford Nanopore Technologies and Boston-based infectious disease diagnostics firm Day Zero Diagnostics have announced a partnership to develop an end-to-end solution for the diagnosis of bloodstream infections.
November 20, 2023
PLK1 inhibitors show promise for inflammatory disease treatment, study shows
A cancer drug in late-stage clinical trials could offer hope for treating a wide range of inflammatory diseases, including gout and heart disease, say researchers.
November 14, 2023
Genomics England, Oxford Nanopore to collaborate on sequencing rare diseases
Genomics England and Oxford Nanopore Technologies have announced a strategic research partnership to resolve undiagnosed rare disease cases.
November 7, 2023
Pharma companies back project to create largest African ancestry genomics research database
AstraZeneca, Novo Nordisk, Regeneron, and Roche have backed a project to create the largest African ancestry genomics research database.
October 25, 2023
Targeting feeder cells reverses prostate cancer’s resistance to treatment in study
Scientists have found a way to reverse prostate cancer’s resistance to drugs in research, which they say could have a broad impact across multiple cancer types.
October 24, 2023
Oxford Nanopore to receive $84.6M investment from BioMĂ©rieux, enters collaboration with Mayo Clinic
Oxford Nanopore is receiving a strategic investment of 70 million pounds ($84.6 million) from in vitro diagnostics (IVD) company BioMĂ©rieux. In addition, the firm has entered a collaboration with the Mayo Clinic on test development.
October 19, 2023
ARUP launches new collaborative research institute
ARUP Industries is hoping to “push the boundaries of diagnostic medicine” via the launch of a new research institute that aims to forge collaborations with industry and community partners.
October 18, 2023
Page 1 of 36
Next Page
